2020
DOI: 10.2967/jnumed.119.229443
|View full text |Cite
|
Sign up to set email alerts
|

Neuroinflammation PET Imaging: Current Opinion and Future Directions

Abstract: Neuroinflammation is a key pathologic hallmark of numerous neurologic diseases, however, its exact role in vivo is yet to be fully understood. PET imaging enables investigation, quantification, and tracking of different neuroinflammation biomarkers in living subjects longitudinally. One such biomarker that has been imaged extensively using PET is translocator protein 18 kDa (TSPO). Although imaging TSPO has yielded valuable clinical data linking neuroinflammation to various neurodegenerative diseases, consider… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
70
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 82 publications
(70 citation statements)
references
References 38 publications
0
70
0
Order By: Relevance
“…Given prior results focusing on monocytic responses in this population, future neuroimaging work should seek methods for monitoring brain macrophagic reesponses. Despite the shortcomings of TSPO radioligands, TSPO PET remains the most widely used tool for assessing neuroinflammation and there is currently no better validated inflammatory radiotracer available (for review, see ( Jain et al., 2020 )).…”
Section: Discussionmentioning
confidence: 99%
“…Given prior results focusing on monocytic responses in this population, future neuroimaging work should seek methods for monitoring brain macrophagic reesponses. Despite the shortcomings of TSPO radioligands, TSPO PET remains the most widely used tool for assessing neuroinflammation and there is currently no better validated inflammatory radiotracer available (for review, see ( Jain et al., 2020 )).…”
Section: Discussionmentioning
confidence: 99%
“…and relevant neuropathology. Future studies integrating emerging markers of synaptic function and neuroinflammation (e.g., PET markers of synaptic vesicle and translocator proteins 30 ), as well as neuropathological assessment are key to this goal. Studies in LGI1 antibody encephalitis patients may be particularly insightful as the LGI1 protein is most strongly expressed in the hippocampus, 31 and LGI1 antibody encephalitis preferentially affects older individuals, 1,2 who are most susceptible to AD neuropathology.…”
Section: Discussionmentioning
confidence: 99%
“…One way to identify pain generators is through the use of positron emission tomography (PET), a noninvasive imaging tool that allows spatiotemporal visualization of cellular responses to injury. PET ligands that specifically target different cell types and varying cellular activation states can be utilized to monitor disease progression or measure treatment success ( Jain et al, 2020 ). We previously used longitudinal 18 F-TSPO-PET imaging in the tibial fracture mouse model to track the activation of peripheral and central myeloid cells during the acute-to-chronic pain transition ( Cropper et al, 2019 ).…”
Section: Pre-clinical Measurements In Orthopedic Trauma: Connection Tmentioning
confidence: 99%